Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 6, 2012, Pages 2138-2143

  Carhart Harris, Robin L ^a,b   Erritzoe, David ^a,c   Williams, Tim ^b   Stone, James M ^a   Reed, Laurence J ^a   Colasanti, Alessandro ^a   Tyacke, Robin J ^a   Leech, Robert ^d   Malizia, Andrea L ^b   Murphy, Kevin ^e   Hobden, Peter ^e   Evans, John ^e   Feilding, Amanda ^f   Wise, Richard G ^e   Nutt, David J ^a,b  

^a Neuropsychopharmacology Unit   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

^f THE BECKLEY FOUNDATION   (United Kingdom)

Author keywords

5 HT2A receptor; Default mode network; Depression; Hallucinogens; Serotonin

Indexed keywords

PLACEBO; PSILOCYBINE;

ADULT; ANTERIOR CINGULATE; ARTICLE; BLOOD OXYGENATION; BRAIN FUNCTION; BRAIN MAPPING; CONSCIOUSNESS; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OXYGEN BLOOD LEVEL; POSTERIOR CINGULATE; PRIORITY JOURNAL; SPIN LABELING; THALAMUS; VENTROMEDIAL PREFRONTAL CORTEX;

ADULT; ARTERIES; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; FEMALE; HALLUCINOGENS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; OXYGEN; PERFUSION; PREFRONTAL CORTEX; PSILOCYBINE; SPIN LABELS;

PSILOCYBE CUBENSIS;

EID: 84857129869     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1119598109     Document Type: Article

References (50)

1. Wasson GR (1957) Seeking the magic mushroom. Life Magazine, May 15:109-120.
2. Grob CS, et al. (2011) Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry 68:71-78.
3. Griffiths RR, Richards WA, McCann U, Jesse R (2006) Psilocybin can occasion mysticaltype experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl) 187:268-283, discussion 284-292.
4. Griffiths R, Richards W, Johnson M, McCann U, Jesse R (2008) Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. J Psychopharmacol 22:621-632.
5. Carhart-Harris RL, et al. (2010) The administration of psilocybin to healthy, hallucinogen- experienced volunteers in a mock-functional magnetic resonance imaging environment: A preliminary investigation of tolerability. J Psychopharmacol 25:1562-1567.
6. Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX (2004) Acute psychological and physiological effects of psilocybin in healthy humans: A double-blind, placebocontrolled dose-effect study. Psychopharmacology (Berl) 172:145-156. (Pubitemid 38388763)
7. Murphy K, Harris AD, Wise RG (2011) Robustly measuring vascular reactivity differences with breath-hold: normalising stimulus-evoked and resting state BOLD fMRI data. Neuroimage 54:369-379.
8. Vollenweider FX, et al. (1997) Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology 16:357-372. (Pubitemid 27211734)
9. Páleníček T, et al. (2011) Comparison of the effects of hallucinogens psilocin and mescaline on quantitative EEG and sensorimotor gating - an animal model of psychosis. Psychiatrie 15:44-48.
10. Shmuel A, Leopold DA (2008) Neuronal correlates of spontaneous fluctuations in fMRI signals in monkey visual cortex: Implications for functional connectivity at rest. Hum Brain Mapp 29:751-761. (Pubitemid 351813076)
11. Nichols DE (2004) Hallucinogens. Pharmacol Ther 101:131-181. (Pubitemid 38167565)
12. Glennon RA, Titeler M, McKenney JD (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2505-2511. (Pubitemid 15212191)
13. Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, Vogel H, Hell D (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9:3897-3902. (Pubitemid 29189323)
14. Shen RY, Andrade R (1998) 5-Hydroxytryptamine2 receptor facilitates GABAergic neurotransmission in rat hippocampus. J Pharmacol Exp Ther 285:805-812.
15. Scruggs JL, Schmidt D, Deutch AY (2003) The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]- 2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats. Neurosci Lett 346:137-140. (Pubitemid 36829280)
16. Abi-Saab WM, Bubser M, Roth RH, Deutch AY (1999) 5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex. Neuropsychopharmacology 20: 92-96. (Pubitemid 29010343)
17. Zhang QJ, et al. (2010) Unilateral lesion of the nigrostriatal pathway decreases the response of interneurons in medial prefrontal cortex to 5-HT 2A/2C receptor stimulation in the rat. Brain Res 1312:127-137.
18. Ashby CR, Jr., Jiang LH, Kasser RJ, Wang RY (1990) Electrophysiological characterization of 5-hydroxytryptamine2 receptors in the rat medial prefrontal cortex. J Pharmacol Exp Ther 252:171-178. (Pubitemid 20067710)
19. Marek GJ, Aghajanian GK (1996) LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. J Pharmacol Exp Ther 278:1373-1382.
20. el Mansari M, Blier P (1997) In vivo electrophysiological characterization of 5-HT receptors in the guinea pig head of caudate nucleus and orbitofrontal cortex. Neuropharmacology 36:577-588.
21. Bergqvist PB, Dong J, Blier P (1999) Effect of atypical antipsychotic drugs on 5-HT2 receptors in the rat orbito-frontal cortex: An in vivo electrophysiological study. Psychopharmacology (Berl) 143:89-96. (Pubitemid 29189999)
22. Anderson IM, et al. (2002) 5-HT(2C) receptor activation by m-chlorophenylpiperazine detected in humans with fMRI. Neuroreport 13:1547-1551. (Pubitemid 34970155)
23. McKie S, et al. (2005) Neuronal effects of acute citalopram detected by pharmacoMRI. Psychopharmacology (Berl) 180:680-686. (Pubitemid 41317864)
24. Andrade R (2011) Serotonergic regulation of neuronal excitability in the prefrontal cortex. Neuropharmacology 61:382-386.
25. Alexander GM, et al. (2009) Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors. Neuron 63:27-39.
26. Raichle ME, et al. (2001) A default mode of brain function. Proc Natl Acad Sci USA 98: 676-682. (Pubitemid 32105102)
27. Buckner RL, Andrews-Hanna JR, Schacter DL (2008) The brain's default network: Anatomy, function, and relevance to disease. Ann N Y Acad Sci 1124:1-38. (Pubitemid 351506788)
28. Raichle ME (1998) The neural correlates of consciousness: An analysis of cognitive skill learning. Philos Trans R Soc Lond B Biol Sci 353:1889-1901.
29. Gusnard DA, Akbudak E, Shulman GL, Raichle ME (2001) Medial prefrontal cortex and self-referential mental activity: Relation to a default mode of brain function. Proc Natl Acad Sci USA 98:4259-4264. (Pubitemid 32249932)
30. Carhart-Harris RL, Mayberg HS, Malizia AL, Nutt D (2008) Mourning and melancholia revisited: Correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry. Ann Gen Psychiatry 7:9.
31. Carhart-Harris RL, Friston KJ (2010) The default-mode, ego-functions and free-energy: A neurobiological account of Freudian ideas. Brain 133:1265-1283.
32. Hagmann P, et al. (2008) Mapping the structural core of human cerebral cortex. PLoS Biol 6:e159.
33. Bullmore E, et al. (2009) Generic aspects of complexity in brain imaging data and other biological systems. Neuroimage 47:1125-1134.
34. Huxley A (1954) The Doors of Perception and Heaven and Hell (Harper & Brothers, London).
35. Friston K (2010) The free-energy principle: A unified brain theory? Nat Rev Neurosci 11:127-138.
36. Sessa B (2005) Can psychedelics have a role in psychiatry once again? Br J Psychiatry 186:457-458.
37. Drevets WC, Price JL, Furey ML (2008) Brain structural and functional abnormalities in mood disorders: Implications for neurocircuitry models of depression. Brain Struct Funct 213:93-118.
38. Sheline YI, Price JL, Yan Z, Mintun MA (2010) Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proc Natl Acad Sci USA 107:11020-11025.
39. Holtzheimer PE, Mayberg HS (2011) Stuck in a rut: Rethinking depression and its treatment. Trends Neurosci 34:1-9.
40. Bhagwagar Z, et al. (2006) Increased 5-HT(2A) receptor binding in euthymic, medication- free patients recovered from depression: A positron emission study with [(11) C]MDL 100,907. Am J Psychiatry 163:1580-1587. (Pubitemid 44465759)
41. Meyer JH, et al. (2003) Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. Am J Psychiatry 160:90-99. (Pubitemid 36042431)
42. Farb NA, Anderson AK, Bloch RT, Segal ZV (2011) Mood-linked responses in medial prefrontal cortex predict relapse in patients with recurrent unipolar depression. Biol Psychiatry 70:366-372.
43. Griffiths RR, et al. (2011) Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. J Psychopharmacol 25: 1453-1461.
44. Sewell RA, Halpern JH, Pope HG, Jr. (2006) Response of cluster headache to psilocybin and LSD. Neurology 66:1920-1922. (Pubitemid 44049828)
45. May A, Bahra A, Büchel C, Frackowiak RS, Goadsby PJ (1998) Hypothalamic activation in cluster headache attacks. Lancet 352:275-278. (Pubitemid 28340145)
46. Franzini A, Messina G, Cordella R, Marras C, Broggi G (2010) Deep brain stimulation of the posteromedial hypothalamus: Indications, long-term results, and neurophysiological considerations. Neurosurg Focus 29:E13.
47. Glover GH, Li T-Q, Ress D (2000) Image-based method for retrospective correction of physiological motion effects in fMRI: RETROICOR. Magn Reson Med 44:162-167. (Pubitemid 30439852)
48. Shmueli K, et al. (2007) Low-frequency fluctuations in the cardiac rate as a source of variance in the resting-state fMRI BOLD signal. Neuroimage 38:306-320. (Pubitemid 47534282)
49. Birn RM, Diamond JB, Smith MA, Bandettini PA (2006) Separating respiratory-variation- related fluctuations from neuronal-activity-related fluctuations in fMRI. Neuroimage 31:1536-1548. (Pubitemid 44192499)
50. Wise RG, Ide K, Poulin MJ, Tracey I (2004) Resting fluctuations in arterial carbon dioxide induce significant low frequency variations in BOLD signal. Neuroimage 21: 1652-1664. (Pubitemid 38446588)